FusionNeoAntigen Logo

Home

Download

Statistics

Examples

Help

Contact

Terms of Use

Center for Computational Systems Medicine
leaf

Fusion Gene and Fusion Protein Summary

leaf

Fusion Amino Acid Sequences (multiple BPs and multiple gene isoforms)

leaf

Fusion Protein Breakpoint Sequences - (for the Screening of the FusionNeoAntigens)

leaf

Potential FusionNeoAntigens in HLA I - (netMHCpan v4.1 + deepHLApan v1.1)

leaf

Potential FusionNeoAntigens in HLA II - (netMHCIIpan v4.1)

leaf

Fusion Breakpoint 14 AA Peptide Structure - (RoseTTAFold)

leaf

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D - (Glide)

leaf

Vaccine Design for the FusionNeoAntigens (RNA/protein sequences)

leaf

Potential target of CAR-T therapy development

leaf

Information on the samples that have these potential fusion neoantigens

leaf

Fusion Protein Targeting Drugs - (Manual Curation)

leaf

Fusion Protein Related diseases - (Manual Curation)

Fusion Protein:MAP1S-CRTC1

Fusion Gene and Fusion Protein Summary

check button Fusion gene summary
Fusion partner gene informationFusion gene name: MAP1S-CRTC1
FusionPDB ID: 51165
FusionGDB2.0 ID: 51165
HgeneTgene
Gene symbol

MAP1S

CRTC1

Gene ID

55201

23373

Gene namemicrotubule associated protein 1SCREB regulated transcription coactivator 1
SynonymsBPY2IP1|C19orf5|MAP8|VCY2IP-1|VCY2IP1MAML2|MECT1|Mam-2|TORC-1|TORC1|WAMTP1
Cytomap

19p13.11

19p13.11

Type of geneprotein-codingprotein-coding
Descriptionmicrotubule-associated protein 1SBPY2-interacting protein 1MAP-1SVCY2-interacting protein 1microtubule-associated protein 8variable charge Y chromosome 2-interacting protein 1CREB-regulated transcription coactivator 1Mastermind-like protein 2mucoepidermoid carcinoma translocated protein 1transducer of regulated cAMP response element-binding protein (CREB) 1
Modification date2020031320200313
UniProtAcc

Q66K74

Main function of 5'-partner protein: FUNCTION: Microtubule-associated protein that mediates aggregation of mitochondria resulting in cell death and genomic destruction (MAGD). Plays a role in anchoring the microtubule organizing center to the centrosomes. Binds to DNA. Plays a role in apoptosis. Involved in the formation of microtubule bundles (By similarity). {ECO:0000250, ECO:0000269|PubMed:15899810, ECO:0000269|PubMed:17234756}.

Q6UUV9

Main function of 5'-partner protein: FUNCTION: Transcriptional coactivator for CREB1 which activates transcription through both consensus and variant cAMP response element (CRE) sites. Acts as a coactivator, in the SIK/TORC signaling pathway, being active when dephosphorylated and acts independently of CREB1 'Ser-133' phosphorylation. Enhances the interaction of CREB1 with TAF4. Regulates the expression of specific CREB-activated genes such as the steroidogenic gene, StAR. Potent coactivator of PGC1alpha and inducer of mitochondrial biogenesis in muscle cells. In the hippocampus, involved in late-phase long-term potentiation (L-LTP) maintenance at the Schaffer collateral-CA1 synapses. May be required for dendritic growth of developing cortical neurons (By similarity). In concert with SIK1, regulates the light-induced entrainment of the circadian clock. In response to light stimulus, coactivates the CREB-mediated transcription of PER1 which plays an important role in the photic entrainment of the circadian clock. {ECO:0000250|UniProtKB:Q157S1, ECO:0000250|UniProtKB:Q68ED7, ECO:0000269|PubMed:23699513}.; FUNCTION: (Microbial infection) Plays a role of coactivator for TAX activation of the human T-cell leukemia virus type 1 (HTLV-1) long terminal repeats (LTR). {ECO:0000269|PubMed:16809310}.
Ensembl transtripts involved in fusion geneENST idsENST00000324096, ENST00000544059, 
ENST00000597681, 
ENST00000321949, 
ENST00000338797, ENST00000594658, 
ENST00000601916, 
Fusion gene scores for assessment (based on all fusion genes of FusionGDB 2.0)* DoF score3 X 4 X 3=369 X 8 X 8=576
# samples 410
** MAII scorelog2(4/36*10)=0.15200309344505
effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs).
DoF>8 and MAII>0
log2(10/576*10)=-2.52606881166759
possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs).
DoF>8 and MAII<0
Fusion gene context

PubMed: MAP1S [Title/Abstract] AND CRTC1 [Title/Abstract] AND fusion [Title/Abstract]

Fusion neoantigen context

PubMed: MAP1S [Title/Abstract] AND CRTC1 [Title/Abstract] AND neoantigen [Title/Abstract]

Most frequent breakpoint (based on all fusion genes of FusionGDB 2.0)MAP1S(17844237)-CRTC1(18853720), # samples:2
Anticipated loss of major functional domain due to fusion event.MAP1S-CRTC1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
MAP1S-CRTC1 seems lost the major protein functional domain in Hgene partner, which is a CGC by not retaining the major functional domain in the partially deleted in-frame ORF.
MAP1S-CRTC1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
MAP1S-CRTC1 seems lost the major protein functional domain in Hgene partner, which is a essential gene by not retaining the major functional domain in the partially deleted in-frame ORF.
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types
** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10)

check button Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez
PartnerGeneGO IDGO termPubMed ID
HgeneMAP1S

GO:0010848

regulation of chromatin disassembly

12762840

TgeneCRTC1

GO:0045944

positive regulation of transcription by RNA polymerase II

14536081



check button Four levels of functional features of fusion genes
Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr19:17844237/chr19:18853720)
- FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels.
- How to search
1. Put your fusion gene symbol.
2. Press the tab key until there will be shown the breakpoint information filled.
4. Go down and press 'Search' tab twice.
4. Go down to have the hyperlink of the search result.
5. Click the hyperlink.
6. See the FGviewer result for your fusion gene.
FGviewer

check buttonRetention analysis results of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features, are available here.

check buttonFusion gene breakpoints across MAP1S (5'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure

check buttonFusion gene breakpoints across CRTC1 (3'-gene)
* Click on the image to open the UCSC genome browser with custom track showing this image in a new window.
all structure


Top

Fusion Amino Acid Sequences


check buttonFusion information from ORFfinder translation from full-length transcript sequence from FusionPDB.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandSeq length
(transcript)
BP loci
(transcript)
Predicted start
(transcript)
Predicted stop
(transcript)
Seq length
(amino acids)
ENST00000324096MAP1Schr1917844237+ENST00000321949CRTC1chr1918853720+5524317511249531613
ENST00000324096MAP1Schr1917844237+ENST00000338797CRTC1chr1918853720+9814317511250011629
ENST00000324096MAP1Schr1917844237+ENST00000594658CRTC1chr1918853720+5524317511249531613
ENST00000324096MAP1Schr1917844237+ENST00000601916CRTC1chr1918853720+5009317511244521446
ENST00000544059MAP1Schr1917844237+ENST00000321949CRTC1chr1918853720+5530318119649591587
ENST00000544059MAP1Schr1917844237+ENST00000338797CRTC1chr1918853720+9820318119650071603
ENST00000544059MAP1Schr1917844237+ENST00000594658CRTC1chr1918853720+5530318119649591587
ENST00000544059MAP1Schr1917844237+ENST00000601916CRTC1chr1918853720+5015318119644581420

check buttonDeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated.
HenstTenstHgeneHchrHbpHstrandTgeneTchrTbpTstrandNo-coding scoreCoding score
ENST00000324096ENST00000321949MAP1Schr1917844237+CRTC1chr1918853720+0.0057834720.99421644
ENST00000324096ENST00000338797MAP1Schr1917844237+CRTC1chr1918853720+0.0025908910.99740916
ENST00000324096ENST00000594658MAP1Schr1917844237+CRTC1chr1918853720+0.0057834720.99421644
ENST00000324096ENST00000601916MAP1Schr1917844237+CRTC1chr1918853720+0.0084487940.99155116
ENST00000544059ENST00000321949MAP1Schr1917844237+CRTC1chr1918853720+0.0067021580.9932979
ENST00000544059ENST00000338797MAP1Schr1917844237+CRTC1chr1918853720+0.0028934580.9971065
ENST00000544059ENST00000594658MAP1Schr1917844237+CRTC1chr1918853720+0.0067021580.9932979
ENST00000544059ENST00000601916MAP1Schr1917844237+CRTC1chr1918853720+0.0098895630.99011046

check button Predicted full-length fusion amino acid sequences. For individual full-length fusion transcript sequence from FusionPDB, we ran ORFfinder and chose the longest ORF among all the predicted ones.

Get the fusion protein sequences from here.

Fusion protein sequence information is available in the fasta format.
>FusionGDB ID_FusionGDB isoform ID_FGname_Hgene_Hchr_Hbp_Henst_Tgene_Tchr_Tbp_Tenst_length(fusion AA) seq_BP

Top

Fusion Protein Breakpoint Sequences for MAP1S-CRTC1

check button +/-13 AA sequence from the breakpoints of the fusion protein sequences.
HgeneHchrHbpTgeneTchrTbpLength(fusion protein)BP in fusion proteinPeptide
MAP1Schr1917844237CRTC1chr191885372031751020ALLASKQHWDRDLQLQLQKSQYLQLG
MAP1Schr1917844237CRTC1chr19188537203181994ALLASKQHWDRDLQLQLQKSQYLQLG

Top

Potential FusionNeoAntigen Information of MAP1S-CRTC1 in HLA I

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.
MAP1S-CRTC1_17844237_18853720.msa

check button Potential FusionNeoAntigen Information
* We used NetMHCpan v4.1 (%rank<0.5) and deepHLApan v1.1 (immunogenic score>0.5)
Fusion geneHchrHbpTgeneTchrTbpHLA IFusionNeoAntigen peptideBinding scoreImmunogenic scoreNeoantigen start (at BP 13)Neoantigen end (at BP 13)
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B14:02DRDLQLQL0.99980.9577917
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B14:01DRDLQLQL0.99980.9577917
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:24DRDLQLQL0.99940.9416917
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:01DRDLQLQL0.99930.9777917
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B38:01DRDLQLQL0.99910.9948917
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B38:02DRDLQLQL0.99910.9938917
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:37DRDLQLQL0.9980.8298917
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:10DRDLQLQL0.99520.8087917
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:01QHWDRDLQL0.99940.9841615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:24QHWDRDLQL0.99940.8778615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:06QHWDRDLQL0.99930.9545615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:13QHWDRDLQL0.99860.9941615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B38:02QHWDRDLQL0.99840.9937615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B38:01QHWDRDLQL0.99810.9932615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B14:02QHWDRDLQL0.99350.9564615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B14:01QHWDRDLQL0.99350.9564615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:10QHWDRDLQL0.99030.8189615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B40:02WDRDLQLQL0.98870.8728817
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:37QHWDRDLQL0.93060.7699615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:18QHWDRDLQL0.890.8997615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B40:05WDRDLQLQL0.86250.8592817
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B37:01WDRDLQLQL0.83750.5611817
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B41:02WDRDLQLQL0.65790.8416817
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B48:01QHWDRDLQL0.56430.8904615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B47:01WDRDLQLQL0.38640.7509817
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B07:10QHWDRDLQL0.05950.7868615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:01LQLQLQKSQY0.99960.67851222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B48:01KQHWDRDLQL0.99410.868515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:25LQLQLQKSQY0.97160.78911222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B38:01KQHWDRDLQL0.84140.988515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:13KQHWDRDLQL0.84080.9838515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:03LQLQLQKSQY0.83630.58031222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B38:02KQHWDRDLQL0.82190.988515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B47:01KQHWDRDLQL0.80870.6884515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-A02:21KQHWDRDLQL0.7840.7263515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B13:02KQHWDRDLQL0.76420.9273515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B13:01KQHWDRDLQL0.72120.9816515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:24QHWDRDLQLQL0.99990.9774617
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:01QHWDRDLQLQL0.99990.9935617
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:24SKQHWDRDLQL0.99980.8664415
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B38:01QHWDRDLQLQL0.99980.9979617
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B38:02QHWDRDLQLQL0.99980.9979617
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:01SKQHWDRDLQL0.99920.9345415
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B38:01SKQHWDRDLQL0.99720.9821415
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B38:02SKQHWDRDLQL0.9970.981415
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:10QHWDRDLQLQL0.99080.9159617
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:10SKQHWDRDLQL0.98880.6348415
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:37QHWDRDLQLQL0.97340.9193617
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:37SKQHWDRDLQL0.97120.7133415
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B07:10QHWDRDLQLQL0.81290.8669617
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C04:10HWDRDLQL10.9876715
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C04:07HWDRDLQL10.988715
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:09DRDLQLQL0.99940.9707917
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:12DRDLQLQL0.99920.9791917
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:05DRDLQLQL0.99890.9745917
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B14:03DRDLQLQL0.98430.9677917
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C04:14HWDRDLQL0.97320.9875715
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:09QHWDRDLQL0.99950.9645615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:12QHWDRDLQL0.99920.9848615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:05QHWDRDLQL0.99820.9829615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C07:29QHWDRDLQL0.86620.9789615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C07:13QHWDRDLQL0.85930.9764615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C07:05QHWDRDLQL0.85370.988615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C07:80QHWDRDLQL0.83650.9854615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C07:67QHWDRDLQL0.83650.9854615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C07:27QHWDRDLQL0.82810.984615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C07:10QHWDRDLQL0.82150.9893615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C07:95QHWDRDLQL0.81180.9118615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C07:46QHWDRDLQL0.81150.9744615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C07:19QHWDRDLQL0.810.9268615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:08QHWDRDLQL0.79880.9909615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B14:03QHWDRDLQL0.66440.9567615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B48:03QHWDRDLQL0.33980.8286615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C12:16QHWDRDLQL0.26660.9836615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C04:07HWDRDLQLQL0.99990.9928717
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C04:10HWDRDLQLQL0.99990.9924717
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:04LQLQLQKSQY0.9860.68471222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B48:03KQHWDRDLQL0.96210.7122515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C04:14HWDRDLQLQL0.93460.9919717
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:08KQHWDRDLQL0.88950.9872515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:05LQLQLQKSQY0.84040.76741222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:05KQHWDRDLQL0.79970.9568515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:09QHWDRDLQLQL0.99990.9836617
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:12QHWDRDLQLQL0.99980.9938617
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:05QHWDRDLQLQL0.99970.9928617
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:09SKQHWDRDLQL0.99960.9082415
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:05SKQHWDRDLQL0.99390.9262415
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C18:01HWDRDLQL10.9855715
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C04:01HWDRDLQL10.988715
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:31DRDLQLQL0.99940.9778917
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B38:05DRDLQLQL0.99910.9948917
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:09DRDLQLQL0.99160.9215917
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:11DRDLQLQL0.99030.9716917
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C04:04HWDRDLQL0.98470.9872715
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:02QHWDRDLQL0.99940.994615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:31QHWDRDLQL0.99930.9838615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B38:05QHWDRDLQL0.99810.9932615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B40:40WDRDLQLQL0.98590.8851817
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:09QHWDRDLQL0.98210.9455615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C18:01QHWDRDLQL0.92830.982615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C07:17QHWDRDLQL0.83850.9862615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C07:04QHWDRDLQL0.83820.9728615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C07:02QHWDRDLQL0.83650.9854615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:11QHWDRDLQL0.8340.9741615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C07:01QHWDRDLQL0.79220.9004615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C07:22QHWDRDLQL0.79080.9204615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C04:04QHWDRDLQL0.73730.9864615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C06:06QHWDRDLQL0.7110.9961615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B40:12QHWDRDLQL0.33980.8286615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B48:05QHWDRDLQL0.14840.7294615
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C04:01HWDRDLQLQL0.99990.9928717
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C18:01HWDRDLQLQL0.99980.9923717
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:33LQLQLQKSQY0.99960.67851222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:27LQLQLQKSQY0.99960.71441222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:125LQLQLQKSQY0.99960.67851222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:34LQLQLQKSQY0.99960.67851222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:135LQLQLQKSQY0.99950.68861222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:50LQLQLQKSQY0.99930.75971222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:24LQLQLQKSQY0.99880.73781222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:53LQLQLQKSQY0.99730.64371222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:35LQLQLQKSQY0.99660.64631222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:12LQLQLQKSQY0.99640.80441222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B40:40KQHWDRDLQL0.99190.6168515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:73KQHWDRDLQL0.99030.9828515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:30KQHWDRDLQL0.97790.9641515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:54LQLQLQKSQY0.97590.60051222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:39LQLQLQKSQY0.97450.67271222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B40:12KQHWDRDLQL0.96210.7122515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-C04:04HWDRDLQLQL0.94010.9925717
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:02KQHWDRDLQL0.91370.9829515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:20LQLQLQKSQY0.84350.84321222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B40:49KQHWDRDLQL0.84210.6913515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B38:05KQHWDRDLQL0.84140.988515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B35:28LQLQLQKSQY0.82270.84441222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B40:21KQHWDRDLQL0.79830.82515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-A02:14KQHWDRDLQL0.78870.6635515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-A02:06KQHWDRDLQL0.7840.7263515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B48:05KQHWDRDLQL0.72640.6031515
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B48:02LQLQLQKSQY0.62360.82521222
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:31QHWDRDLQLQL0.99990.9934617
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B38:05QHWDRDLQLQL0.99980.9979617
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:31SKQHWDRDLQL0.99920.9349415
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B38:05SKQHWDRDLQL0.99720.9821415
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:11QHWDRDLQLQL0.99680.9895617
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:09QHWDRDLQLQL0.99580.9799617
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B39:11SKQHWDRDLQL0.99330.9375415
MAP1S-CRTC1chr1917844237chr19188537203175HLA-B15:09SKQHWDRDLQL0.98250.9045415

Top

Potential FusionNeoAntigen Information of MAP1S-CRTC1 in HLA II

check button Multiple sequence alignments of the potential FusionNeoAntigens per fusion breakpoints. If the MSA is empty, then it means that there were predicted fusion neoantigens in this fusion breakpoint, but those predicted fusion neoantigens were not across the breakpoint, which is not fusion-specific.

check button Potential FusionNeoAntigen Information
* We used NetMHCIIpan v4.1 (%rank<0.5).
Fusion geneHchrHbpTgeneTchrTbpHLA IIFusionNeoAntigen peptideNeoantigen start (at BP 13)Neoantigen end (at BP 13)

Top

Fusion breakpoint peptide structures of MAP1S-CRTC1

check button3D structures of the fusion breakpoint peptide of 14AA sequence that have potential fusion neoantigens
* The minimum length of the amino acid sequence in RoseTTAFold is 14AA. Here, we predicted the 14AA fusion protein breakpoint sequence not the fusion neoantigen peptide, which is shorter than 14 AA.
File nameBPseqHgeneTgeneHchrHbpTchrTbpAAlen
7311QHWDRDLQLQLQKSMAP1SCRTC1chr1917844237chr19188537203175

Top

Filtering FusionNeoAntigens Through Checking the Interaction with HLAs in 3D of MAP1S-CRTC1

check buttonVirtual screening between 25 HLAs (from PDB) and FusionNeoAntigens
* We used Glide to predict the interaction between HLAs and neoantigens.
HLA allelePDB IDFile nameBPseqDocking scoreGlide score
HLA-B14:023BVN7311QHWDRDLQLQLQKS-7.15543-7.26883
HLA-B14:023BVN7311QHWDRDLQLQLQKS-4.77435-5.80965
HLA-B52:013W397311QHWDRDLQLQLQKS-6.80875-6.92215
HLA-B52:013W397311QHWDRDLQLQLQKS-4.20386-5.23916
HLA-A11:014UQ27311QHWDRDLQLQLQKS-7.5194-8.5547
HLA-A11:014UQ27311QHWDRDLQLQLQKS-6.9601-7.0735
HLA-A24:025HGA7311QHWDRDLQLQLQKS-7.52403-7.63743
HLA-A24:025HGA7311QHWDRDLQLQLQKS-5.82433-6.85963
HLA-B27:056PYJ7311QHWDRDLQLQLQKS-3.28285-4.31815
HLA-B44:053DX87311QHWDRDLQLQLQKS-5.91172-6.94702
HLA-B44:053DX87311QHWDRDLQLQLQKS-4.24346-4.35686

Top

Vaccine Design for the FusionNeoAntigens of MAP1S-CRTC1

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-Is.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptide sequenceFusionNeoAntigen RNA sequence
MAP1S-CRTC1chr1917844237chr19188537201222LQLQLQKSQYCAGCTCCAGCTCCAGAAATCCCAGTACCTG
MAP1S-CRTC1chr1917844237chr1918853720415SKQHWDRDLQLAAGCAGCATTGGGACCGTGACCTGCAGCTCCAG
MAP1S-CRTC1chr1917844237chr1918853720515KQHWDRDLQLCAGCATTGGGACCGTGACCTGCAGCTCCAG
MAP1S-CRTC1chr1917844237chr1918853720615QHWDRDLQLCATTGGGACCGTGACCTGCAGCTCCAG
MAP1S-CRTC1chr1917844237chr1918853720617QHWDRDLQLQLCATTGGGACCGTGACCTGCAGCTCCAGCTCCAG
MAP1S-CRTC1chr1917844237chr1918853720715HWDRDLQLTGGGACCGTGACCTGCAGCTCCAG
MAP1S-CRTC1chr1917844237chr1918853720717HWDRDLQLQLTGGGACCGTGACCTGCAGCTCCAGCTCCAG
MAP1S-CRTC1chr1917844237chr1918853720817WDRDLQLQLGACCGTGACCTGCAGCTCCAGCTCCAG
MAP1S-CRTC1chr1917844237chr1918853720917DRDLQLQLCGTGACCTGCAGCTCCAGCTCCAG

check button mRNA and peptide sequences of FusionNeoAntigens that have potential interaction with HLA-IIs.
Fusion geneHchrHbpTchrTbpStart in +/-13AAEnd in +/-13AAFusionNeoAntigen peptideFusionNEoAntigen RNA sequence

Top

Information of the samples that have these potential fusion neoantigens of MAP1S-CRTC1

check button These samples were reported as having these fusion breakpoints. For individual breakpoints, we checked the open reading frames considering multiple gene isoforms and chose the in-frame fusion genes only. Then, we made fusion protein sequences and predicted the fusion neoantigens. These fusion-positive samples may have these potential fusion neoantigens.
Cancer typeFusion geneHchrHbpHenstTchrTbpTenstSample
UCSMAP1S-CRTC1chr1917844237ENST00000324096chr1918853720ENST00000321949TCGA-N8-A4PN-01A

Top

Potential target of CAR-T therapy development for MAP1S-CRTC1

check button Predicted 3D structure. We used RoseTTAFold.

check buttonRetention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, to provide the retention of the transmembrane domain, we only show the protein feature retention information of those transmembrane features


* Minus value of BPloci means that the break point is located before the CDS.
- In-frame and retained 'Transmembrane'.
PartnerGeneHbpTbpENSTStrandBPexonTotalExonProtein feature loci*BPlociTotalLenProtein featureProtein feature note

check button Subcellular localization prediction of the transmembrane domain retained fusion proteins
* We used DeepLoc 1.0. The order of the X-axis of the barplot is as follows: Entry_ID, Localization, Type, Nucleus, Cytoplasm, Extracellular, Mitochondrion, Cell_membrane, Endoplasmic_reticulum, Plastid, Golgi.apparatus, Lysosome.Vacuole, Peroxisome. Y-axis is the output score of DeepLoc. Clicking the image will open a new tab with a large image.
HgeneHchrHbpHenstTgeneTchrTbpTenstDeepLoc result

Top

Related Drugs to MAP1S-CRTC1

check button Drugs used for this fusion-positive patient.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDrugSourcePMID

Top

Related Diseases to MAP1S-CRTC1

check button Diseases that have this fusion gene.
(Manual curation of PubMed, 04-30-2022 + MyCancerGenome)
HgeneTgeneDiseaseSourcePMID

check button Diseases associated with fusion partners.
(DisGeNet 4.0)
PartnerGeneDisease IDDisease name# pubmedsSource
TgeneCRTC1C0279628Adenocarcinoma Of Esophagus1CTD_human
TgeneCRTC1C0525045Mood Disorders1PSYGENET